ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway

Recently, COVID-19 caused by the novel coronavirus SARS-CoV-2 has brought great challenges to the world. More and more studies have shown that patients with severe COVID-19 may suffer from cytokine storm syndrome; however, there are few studies on its pathogenesis. Here we demonstrated that SARS-CoV...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:iScience 2021-04, Vol.24 (4), p.102293, Article 102293
Hauptverfasser: Lin, Xiaoyuan, Fu, Beibei, Yin, Songna, Li, Zhifeng, Liu, Huawen, Zhang, Haiwei, Xing, Na, Wang, Yu, Xue, Weiwei, Xiong, Yan, Zhang, Shanfu, Zhao, Qingting, Xu, Shiyao, Zhang, Jing, Wang, Peihui, Nian, Weiqi, Wang, Xingsheng, Wu, Haibo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Recently, COVID-19 caused by the novel coronavirus SARS-CoV-2 has brought great challenges to the world. More and more studies have shown that patients with severe COVID-19 may suffer from cytokine storm syndrome; however, there are few studies on its pathogenesis. Here we demonstrated that SARS-CoV-2 coding protein open reading frame 8 (ORF8) acted as a contributing factor to cytokine storm during COVID-19 infection. ORF8 could activate IL-17 signaling pathway and promote the expression of pro-inflammatory factors. Moreover, we demonstrated that treatment of IL17RA antibody protected mice from ORF8-induced inflammation. Our findings are helpful to understand the pathogenesis of cytokine storm caused by SARS-CoV-2 and provide a potential target for the development of COVID-19 therapeutic drugs. [Display omitted] •SARS-CoV-2 ORF8 activates IL-17 signaling pathway by interacting with host IL17RA•Treatment of IL17RA antibody protects mice from ORF8-induced inflammation Biological Sciences; Microbiology; Virology
ISSN:2589-0042
2589-0042
DOI:10.1016/j.isci.2021.102293